At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies
Open Access
- 1 May 1999
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 10 (5) , 511-518
- https://doi.org/10.1023/a:1026427724108
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvementThe Lancet, 1998
- Outpatient Parenteral Antimicrobial-Drug TherapyNew England Journal of Medicine, 1997
- Prophylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescueSupportive Care in Cancer, 1996
- BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1995
- Granulocyte growth factors: Achieving a consensusAnnals of Oncology, 1995
- Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection ProgramAntimicrobial Agents and Chemotherapy, 1994
- A randomized clinical trial of ceftriaxone and teicoplanin versus ceftazidime and teicoplanin as antibiotic therapy in febrile neutropenic cancer patients and bone marrow transplant recipientsInfection, 1994
- Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.Journal of Clinical Oncology, 1994
- Efficacy and Toxicity of Single Daily Doses of Amikacin and Ceftriaxone versus Multiple Daily Doses of Amikacin and Ceftazidime for Infection in Patients with Cancer and GranulocytopeniaAnnals of Internal Medicine, 1993
- Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapyBlood, 1993